NCT03123510

Brief Summary

The objective of the trial is to study how a synbiotic treatment will affect weight loss and management in individuals enrolled in weight loss diet Profile®. The investigators propose to follow up 2 cohorts of Profile® subjects during 6 months. One group will receive a synbiotic treatment supplement (Bifidobacterium spp plus bimuno- galacto-oligosaccharides (B-GOS)) while the other group will receive placebo capsules. Anthropomorphic and metabolic analysis will be performed by-monthly. Fecal samples will be obtained before and after the dietary intervention and samples will be sequenced trough next generation DNA sequencing to analyze the gut microbiota. Because dietary interventions with high protein and low glycemic index have been shown to be effective in reducing weight, but has also been linked to potential colon harm due to increased fermentation of undigested protein on the colon, the investigators expect supplementation of Profile® with a synbiotic product will lead to an increased overall wellbeing without compromising weight management.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

March 29, 2017

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 21, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

April 21, 2017

Status Verified

April 1, 2017

Enrollment Period

5 months

First QC Date

March 29, 2017

Last Update Submit

April 18, 2017

Conditions

Keywords

probioticsprebioticssynbioticsobesity

Outcome Measures

Primary Outcomes (1)

  • Changes in Gut microbiota associated to the synbiotic treatment

    Stools samples will be collected and analyzed before and after the intervention and compared between groups

    3 months

Secondary Outcomes (4)

  • Changes in weight associated to the synbiotic treatment

    3 months

  • Changes in glucose levels associated to the synbiotic treatment

    3 months

  • Changes in body density associated to the synbiotic treatment

    3 months

  • Changes in waist circumference associated to the synbiotic treatment

    3 months

Study Arms (2)

Synbiotic supplement

EXPERIMENTAL

Bifidobacterium spp plus bimuno- galacto-oligosaccharides

Dietary Supplement: Bifidobacterium spp plus bimuno- galacto-oligosaccharides

placebo

PLACEBO COMPARATOR

sugar pills

Dietary Supplement: Placebo

Interventions

Volunteers will be asked to take one probiotic capsule and one prebiotic satchel daily.

Synbiotic supplement
PlaceboDIETARY_SUPPLEMENT

Volunteers will be asked to take one placebo capsule and one placebo satchel daily.

placebo

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any individual aged 18-80 years participating in the Profile weight loss/management diet

You may not qualify if:

  • Pregnant
  • Requires special diets or dietary regimens
  • On long term antibiotic therapy
  • Diagnosed with gastrointestinal diseases (Irritable Bowel syndrome, Crohn's disease or Colitis)
  • Immune compromised
  • Have cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Dakota State University

Brookings, South Dakota, 57007, United States

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • eduardo Huarte, PhD

    South Dakota State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

eduardo huarte, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Neither the volunteers nor the coaches will be aware
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: One group will receive a synbiotic supplement and the other placebo capsules.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Reseacrh Professor

Study Record Dates

First Submitted

March 29, 2017

First Posted

April 21, 2017

Study Start

March 1, 2017

Primary Completion

July 31, 2017

Study Completion

November 1, 2017

Last Updated

April 21, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will share

Result of the study will be made available to the scientific community trough manuscript publication. Each participant will be assigned a code to maintain patient confidentiality.

Locations